Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market in any manner.
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca, Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer, Inc.
Eisai Co. Ltd.
The Procter & Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical, Inc.
BD
EndoGastric Solutions
Medigus Ltd.
Market Segmentation (by Type)
Medication
Minimally Invasive Surgery
Invasive Surgery
Market Segmentation (by Application)
Heartburn
Acid reflux disorders
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market in any manner.
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca, Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer, Inc.
Eisai Co. Ltd.
The Procter & Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical, Inc.
BD
EndoGastric Solutions
Medigus Ltd.
Market Segmentation (by Type)
Medication
Minimally Invasive Surgery
Invasive Surgery
Market Segmentation (by Application)
Heartburn
Acid reflux disorders
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
- Overview of the regional outlook of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
1.2 Key Market Segments
1.2.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Type
1.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Manufacturers (2019-2024)
3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites, Area Served, Product Type
3.6 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Competitive Situation and Trends
3.6.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2019-2024)
6.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Type (2019-2024)
6.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price by Type (2019-2024)
7 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Sales by Application (2019-2024)
7.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2019-2024)
8 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca, Plc.
9.1.1 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.1.2 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.1.4 AstraZeneca, Plc. Business Overview
9.1.5 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
9.1.6 AstraZeneca, Plc. Recent Developments
9.2 Addex Therapeutics
9.2.1 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.2.2 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.2.4 Addex Therapeutics Business Overview
9.2.5 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
9.2.6 Addex Therapeutics Recent Developments
9.3 Takeda Pharmaceutical Company Limited
9.3.1 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.3.2 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
9.3.5 Takeda Pharmaceutical Company Limited Business Overview
9.3.6 Takeda Pharmaceutical Company Limited Recent Developments
9.4 Rottapharm (Meda AB)
9.4.1 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.4.2 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.4.4 Rottapharm (Meda AB) Business Overview
9.4.5 Rottapharm (Meda AB) Recent Developments
9.5 Pfizer, Inc.
9.5.1 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.5.2 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.5.4 Pfizer, Inc. Business Overview
9.5.5 Pfizer, Inc. Recent Developments
9.6 Eisai Co. Ltd.
9.6.1 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.6.2 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.6.4 Eisai Co. Ltd. Business Overview
9.6.5 Eisai Co. Ltd. Recent Developments
9.7 The Procter and Gamble Company
9.7.1 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.7.2 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.7.3 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.7.4 The Procter and Gamble Company Business Overview
9.7.5 The Procter and Gamble Company Recent Developments
9.8 Mederi Therapeutics
9.8.1 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.8.2 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.8.4 Mederi Therapeutics Business Overview
9.8.5 Mederi Therapeutics Recent Developments
9.9 Aros Pharma
9.9.1 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.9.2 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.9.4 Aros Pharma Business Overview
9.9.5 Aros Pharma Recent Developments
9.10 Torax Medical, Inc.
9.10.1 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.10.2 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.10.4 Torax Medical, Inc. Business Overview
9.10.5 Torax Medical, Inc. Recent Developments
9.11 BD
9.11.1 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.11.2 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.11.4 BD Business Overview
9.11.5 BD Recent Developments
9.12 EndoGastric Solutions
9.12.1 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.12.2 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.12.4 EndoGastric Solutions Business Overview
9.12.5 EndoGastric Solutions Recent Developments
9.13 Medigus Ltd.
9.13.1 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.13.2 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.13.4 Medigus Ltd. Business Overview
9.13.5 Medigus Ltd. Recent Developments
10 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET FORECAST BY REGION
10.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast
10.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
10.2.3 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region
10.2.4 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2025-2030)
11.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2025-2030)
11.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Application (2025-2030)
11.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application
11.2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
1.2 Key Market Segments
1.2.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Type
1.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Manufacturers (2019-2024)
3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites, Area Served, Product Type
3.6 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Competitive Situation and Trends
3.6.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2019-2024)
6.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Type (2019-2024)
6.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price by Type (2019-2024)
7 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Sales by Application (2019-2024)
7.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2019-2024)
8 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca, Plc.
9.1.1 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.1.2 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.1.4 AstraZeneca, Plc. Business Overview
9.1.5 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
9.1.6 AstraZeneca, Plc. Recent Developments
9.2 Addex Therapeutics
9.2.1 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.2.2 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.2.4 Addex Therapeutics Business Overview
9.2.5 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
9.2.6 Addex Therapeutics Recent Developments
9.3 Takeda Pharmaceutical Company Limited
9.3.1 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.3.2 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
9.3.5 Takeda Pharmaceutical Company Limited Business Overview
9.3.6 Takeda Pharmaceutical Company Limited Recent Developments
9.4 Rottapharm (Meda AB)
9.4.1 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.4.2 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.4.4 Rottapharm (Meda AB) Business Overview
9.4.5 Rottapharm (Meda AB) Recent Developments
9.5 Pfizer, Inc.
9.5.1 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.5.2 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.5.4 Pfizer, Inc. Business Overview
9.5.5 Pfizer, Inc. Recent Developments
9.6 Eisai Co. Ltd.
9.6.1 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.6.2 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.6.4 Eisai Co. Ltd. Business Overview
9.6.5 Eisai Co. Ltd. Recent Developments
9.7 The Procter and Gamble Company
9.7.1 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.7.2 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.7.3 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.7.4 The Procter and Gamble Company Business Overview
9.7.5 The Procter and Gamble Company Recent Developments
9.8 Mederi Therapeutics
9.8.1 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.8.2 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.8.4 Mederi Therapeutics Business Overview
9.8.5 Mederi Therapeutics Recent Developments
9.9 Aros Pharma
9.9.1 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.9.2 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.9.4 Aros Pharma Business Overview
9.9.5 Aros Pharma Recent Developments
9.10 Torax Medical, Inc.
9.10.1 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.10.2 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.10.4 Torax Medical, Inc. Business Overview
9.10.5 Torax Medical, Inc. Recent Developments
9.11 BD
9.11.1 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.11.2 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.11.4 BD Business Overview
9.11.5 BD Recent Developments
9.12 EndoGastric Solutions
9.12.1 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.12.2 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.12.4 EndoGastric Solutions Business Overview
9.12.5 EndoGastric Solutions Recent Developments
9.13 Medigus Ltd.
9.13.1 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
9.13.2 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
9.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
9.13.4 Medigus Ltd. Business Overview
9.13.5 Medigus Ltd. Recent Developments
10 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET FORECAST BY REGION
10.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast
10.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
10.2.3 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region
10.2.4 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2025-2030)
11.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2025-2030)
11.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Application (2025-2030)
11.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application
11.2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2022)
Table 10. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites and Area Served
Table 12. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
Table 13. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
Table 22. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Type (K Units)
Table 23. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (M USD)
Table 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2019-2024)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Share by Type (2019-2024)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Application
Table 30. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application
Table 31. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2019-2024)
Table 33. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2019-2024)
Table 35. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2019-2024)
Table 38. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 44. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 45. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca, Plc. Business Overview
Table 47. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 48. AstraZeneca, Plc. Recent Developments
Table 49. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 50. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 51. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Addex Therapeutics Business Overview
Table 53. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 54. Addex Therapeutics Recent Developments
Table 55. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 56. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 57. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 59. Takeda Pharmaceutical Company Limited Business Overview
Table 60. Takeda Pharmaceutical Company Limited Recent Developments
Table 61. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 62. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 63. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Rottapharm (Meda AB) Business Overview
Table 65. Rottapharm (Meda AB) Recent Developments
Table 66. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 67. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 68. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pfizer, Inc. Business Overview
Table 70. Pfizer, Inc. Recent Developments
Table 71. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 72. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 73. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eisai Co. Ltd. Business Overview
Table 75. Eisai Co. Ltd. Recent Developments
Table 76. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 77. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 78. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. The Procter and Gamble Company Business Overview
Table 80. The Procter and Gamble Company Recent Developments
Table 81. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 82. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 83. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Mederi Therapeutics Business Overview
Table 85. Mederi Therapeutics Recent Developments
Table 86. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 87. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 88. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Aros Pharma Business Overview
Table 90. Aros Pharma Recent Developments
Table 91. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 92. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 93. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Torax Medical, Inc. Business Overview
Table 95. Torax Medical, Inc. Recent Developments
Table 96. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 97. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 98. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. BD Business Overview
Table 100. BD Recent Developments
Table 101. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 102. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 103. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. EndoGastric Solutions Business Overview
Table 105. EndoGastric Solutions Recent Developments
Table 106. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 107. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 108. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Medigus Ltd. Business Overview
Table 110. Medigus Ltd. Recent Developments
Table 111. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2022)
Table 10. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites and Area Served
Table 12. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
Table 13. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
Table 22. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Type (K Units)
Table 23. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (M USD)
Table 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2019-2024)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Share by Type (2019-2024)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Application
Table 30. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application
Table 31. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2019-2024)
Table 33. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2019-2024)
Table 35. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2019-2024)
Table 38. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 44. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 45. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca, Plc. Business Overview
Table 47. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 48. AstraZeneca, Plc. Recent Developments
Table 49. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 50. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 51. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Addex Therapeutics Business Overview
Table 53. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 54. Addex Therapeutics Recent Developments
Table 55. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 56. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 57. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices SWOT Analysis
Table 59. Takeda Pharmaceutical Company Limited Business Overview
Table 60. Takeda Pharmaceutical Company Limited Recent Developments
Table 61. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 62. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 63. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Rottapharm (Meda AB) Business Overview
Table 65. Rottapharm (Meda AB) Recent Developments
Table 66. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 67. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 68. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pfizer, Inc. Business Overview
Table 70. Pfizer, Inc. Recent Developments
Table 71. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 72. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 73. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eisai Co. Ltd. Business Overview
Table 75. Eisai Co. Ltd. Recent Developments
Table 76. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 77. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 78. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. The Procter and Gamble Company Business Overview
Table 80. The Procter and Gamble Company Recent Developments
Table 81. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 82. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 83. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Mederi Therapeutics Business Overview
Table 85. Mederi Therapeutics Recent Developments
Table 86. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 87. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 88. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Aros Pharma Business Overview
Table 90. Aros Pharma Recent Developments
Table 91. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 92. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 93. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Torax Medical, Inc. Business Overview
Table 95. Torax Medical, Inc. Recent Developments
Table 96. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 97. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 98. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. BD Business Overview
Table 100. BD Recent Developments
Table 101. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 102. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 103. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. EndoGastric Solutions Business Overview
Table 105. EndoGastric Solutions Recent Developments
Table 106. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Basic Information
Table 107. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 108. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Medigus Ltd. Business Overview
Table 110. Medigus Ltd. Recent Developments
Table 111. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD), 2019-2030
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) (2019-2030)
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (M USD)
Figure 11. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Share by Manufacturers in 2023
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers in 2023
Figure 13. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type
Figure 18. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2019-2024)
Figure 19. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2023
Figure 20. Market Size Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application
Figure 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application in 2023
Figure 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2019-2024)
Figure 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application in 2023
Figure 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2023
Figure 32. U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2023
Figure 37. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2023
Figure 44. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 50. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2023
Figure 51. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD), 2019-2030
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) (2019-2030)
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (M USD)
Figure 11. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Share by Manufacturers in 2023
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers in 2023
Figure 13. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type
Figure 18. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2019-2024)
Figure 19. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2023
Figure 20. Market Size Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application
Figure 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application in 2023
Figure 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2019-2024)
Figure 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application in 2023
Figure 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2023
Figure 32. U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2023
Figure 37. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2023
Figure 44. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 50. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2023
Figure 51. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Application (2025-2030)
